J.S. Finlayson - Concepedia

Author

J.S. Finlayson

Also Known As

J Finlayson, J S FINLAYSON, J S Finlayson, J. Finlayson, J. S Finlayson, J. S. Finlayson, J.S Finlayson, J.S. Finlayson, JS Finlayson

111

Publications

4.5K

Citations

H-Index

109

Concepts

All Affiliations

National Institutes of Health Center for Biologics Evaluation and Research United States Food and Drug Administration National Cancer Institute University of Wisconsin–Madison

About

J.S. Finlayson is an author at National Institutes of Health specializing in medicine, bioanalysis, and biochemistry.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	24	37	2.5K
2	Natural Sciences	13	14	1.4K
3	Engineering	4	4	168
4	Public Health	3	3	128
5	Health Sciences	1	1	25

J.S. Finlayson

Publications

3.3K

Citations

H-Index

Page 1

	Year	Citations
Cross-link in Fibrin Polymerized by Factor XIII: ε-(γ-Glutamyl)lysine John J. Pisano, J.S. Finlayson, Marjorie P. Peyton Science Cross-linked Human FibrinBiochemistryCross-linkMedicineNatural Sciences	1968	307
Human Fibrinogen Heterogeneities Michael W. Mosesson, J.S. Finlayson, R.A. Umfleet, Journal of Biological Chemistry PathologyMolecular BiologyPeptide ScienceAnalytical UltracentrifugationProtein Purification	1972	200
Hypotension Associated with Prekallikrein Activator (Hageman-Factor Fragments) in Plasma Protein Fraction Barbara M. Alving, Yoshio Hojima, John J. Pisano, New England Journal of Medicine	1978	199
Major Urinary Protein Complex of Normal Mice: Origin J.S. Finlayson, Richard Asofsky, Michael Potter, Science Amino AcidsMammalian PhysiologyCytoskeletonBioanalysisHepatotoxicity	1965	173
Kinetics of activation and autoactivation of human factor XII Donald L. Tankersley, J.S. Finlayson Biochemistry Protein FunctionSignal TransductionProtein ExpressionBiochemistryReciprocal Activation	1984	169
Human Fibrinogen Heterogeneities Michael W. Mosesson, J.S. Finlayson, R.A. Umfleet Journal of Biological Chemistry GlycobiologyPathologyMolecular BiologyAnalytical UltracentrifugationThrombosis	1972	137
Immunoglobulin G dimer: An idiotype-anti-idiotype complex Donald L. Tankersley, M S Preston, J.S. Finlayson Molecular Immunology Autoimmune DiseaseMedicineImmunodeficienciesImmunologyAutoimmunity	1988	137
Fibrin sealant: summary of a conference on characteristics and clinical uses Barbara M. Alving, Mark Weinstein, J.S. Finlayson, Transfusion Translational MedicineAntifibrinolytic AgentClinical UsesEngineeringPharmacology	1995	120
Generation of the combined prothrombin activation peptide (F1-2) during the clotting of blood and plasma. David L. Aronson, L Stevan, A. P. Ball, Journal of Clinical Investigation ImmunologyPeptide ScienceProthrombin ConversionProtein PurificationThrombosis	1977	116
Fibrinogen Bethesda: a congenital dysfibrinogenemia with delayed fibrinopeptide release H R Gralnick, Harry Givelber, John R. Shainoff, Journal of Clinical Investigation ThrombopoiesisThrombosisMexican-english ExtractionHematologyPediatrics	1971	112

Page 1